President and CEO of Leo Pharma to resign
After more than two years leading the Danish pharmaceutical company, the board of directors and CEO Catherine Mazzacco have agreed she will step down.
President and CEO of Leo Pharma Catherine Mazzacco has led the company in the development of a new capital and governance structure, and according to a press statement, the CEO and board of directors have "concluded that this would be the right time for LEO Pharma to recruit a new CEO."
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Leo Pharma starts phase II trial of Korean tablet
For subscribers
